{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363388846325930752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1126/scitranslmed.3001777"}},{"identifier":{"@type":"URI","@value":"https://www.science.org/doi/pdf/10.1126/scitranslmed.3001777"}}],"dc:title":[{"@value":"Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:p>Central nervous system–directed antisense therapy ameliorates symptoms in a severe neuromuscular disorder in mice.</jats:p>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383388846325930761","@type":"Researcher","foaf:name":[{"@value":"Marco A. Passini"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930755","@type":"Researcher","foaf:name":[{"@value":"Jie Bu"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930752","@type":"Researcher","foaf:name":[{"@value":"Amy M. Richards"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930763","@type":"Researcher","foaf:name":[{"@value":"Cathrine Kinnecom"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930881","@type":"Researcher","foaf:name":[{"@value":"S. Pablo Sardi"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930754","@type":"Researcher","foaf:name":[{"@value":"Lisa M. Stanek"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930753","@type":"Researcher","foaf:name":[{"@value":"Yimin Hua"}],"jpcoar:affiliationName":[{"@value":"Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930764","@type":"Researcher","foaf:name":[{"@value":"Frank Rigo"}],"jpcoar:affiliationName":[{"@value":"Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, CA 92008, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930758","@type":"Researcher","foaf:name":[{"@value":"John Matson"}],"jpcoar:affiliationName":[{"@value":"Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, CA 92008, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930756","@type":"Researcher","foaf:name":[{"@value":"Gene Hung"}],"jpcoar:affiliationName":[{"@value":"Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, CA 92008, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930759","@type":"Researcher","foaf:name":[{"@value":"Edward M. Kaye"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."},{"@value":"Department of Neurology, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02114, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930757","@type":"Researcher","foaf:name":[{"@value":"Lamya S. Shihabuddin"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930760","@type":"Researcher","foaf:name":[{"@value":"Adrian R. Krainer"}],"jpcoar:affiliationName":[{"@value":"Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930880","@type":"Researcher","foaf:name":[{"@value":"C. Frank Bennett"}],"jpcoar:affiliationName":[{"@value":"Isis Pharmaceuticals, 1896 Rutherford Road, Carlsbad, CA 92008, USA."}]},{"@id":"https://cir.nii.ac.jp/crid/1383388846325930762","@type":"Researcher","foaf:name":[{"@value":"Seng H. Cheng"}],"jpcoar:affiliationName":[{"@value":"Genzyme Corporation, 49 New York Avenue, Framingham, MA 01701, USA."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"19466234"},{"@type":"EISSN","@value":"19466242"}],"prism:publicationName":[{"@value":"Science Translational Medicine"}],"dc:publisher":[{"@value":"American Association for the Advancement of Science (AAAS)"}],"prism:publicationDate":"2011-03-02","prism:volume":"3","prism:number":"72","prism:startingPage":"72ra18"},"reviewed":"false","url":[{"@id":"https://www.science.org/doi/pdf/10.1126/scitranslmed.3001777"}],"createdAt":"2011-03-04","modifiedAt":"2024-01-16","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002215823314048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A novel evaluation method of survival motor neuron protein as a biomarker of spinal muscular atrophy by imaging flow cytometry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168087138304","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Spinal Muscular Atrophy: From Gene Discovery to Clinical Trials"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184552008704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Silencing neuronal mutant androgen receptor in a mouse model of spinal and bulbar muscular atrophy"}]},{"@id":"https://cir.nii.ac.jp/crid/1360568466754019840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Peptide-conjugate antisense based splice-correction for Duchenne muscular dystrophy and other neuromuscular diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584340715774080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846642720726656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"TSUNAMI: an antisense method to phenocopy splicing-associated diseases in animals"}]},{"@id":"https://cir.nii.ac.jp/crid/1390845712997271680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"脊髄性筋萎縮症（SMA）治療薬ヌシネルセン（スピンラザ<sup>®</sup>）の薬理学的特徴と臨床試験成績"},{"@language":"en","@value":"Pharmacological and clinical profile of spinal muscular atrophy (SMA) therapeutic drug nusinersen (Spinraza<sup>®</sup>)"},{"@value":"新薬紹介総説 脊髄性筋萎縮症(SMA)治療薬ヌシネルセン(スピンラザ)の薬理学的特徴と臨床試験成績"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ セキズイセイキン イシュクショウ(SMA)チリョウヤク ヌシネルセン(スピンラザ)ノ ヤクリガクテキ トクチョウ ト リンショウ シケン セイセキ"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1126/scitranslmed.3001777"},{"@type":"CROSSREF","@value":"10.1101/gad.197418.112_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"},{"@type":"CROSSREF","@value":"10.1254/fpj.152.147_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"},{"@type":"CROSSREF","@value":"10.1016/j.bbrc.2014.09.087_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"},{"@type":"CROSSREF","@value":"10.1111/ahg.12031_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"},{"@type":"CROSSREF","@value":"10.1093/hmg/ddv300_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"},{"@type":"CROSSREF","@value":"10.1016/j.ebiom.2019.06.036_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"},{"@type":"CROSSREF","@value":"10.3390/ijms241511939_references_DOI_NBYCbj0fZdCg6QzV0AwQG1urHzH"}]}